These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 9275533

  • 1. [Expression of protooncogene bcl-2 in thyroid tumors].
    Zhu J, Chen Y, Xue H.
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):829-31. PubMed ID: 9275533
    [Abstract] [Full Text] [Related]

  • 2. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.
    Mitselou A, Peschos D, Dallas P, Charalabopoulos K, Agnantis NJ, Vougiouklakis T.
    Exp Oncol; 2004 Dec; 26(4):282-6. PubMed ID: 15627060
    [Abstract] [Full Text] [Related]

  • 4. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
    Gui K.
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
    [Abstract] [Full Text] [Related]

  • 5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed M, Al-Sanea O, Uddin S, Al-Kuraya KS.
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [Abstract] [Full Text] [Related]

  • 6. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [Abstract] [Full Text] [Related]

  • 7. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder].
    Leng J, Zhang Y, Yao X, Wen K.
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985
    [Abstract] [Full Text] [Related]

  • 8. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
    Nardone HC, Ziober AF, LiVolsi VA, Mandel SJ, Baloch ZW, Weber RS, Mick R, Ziober BL.
    Cancer; 2003 Oct 01; 98(7):1386-93. PubMed ID: 14508824
    [Abstract] [Full Text] [Related]

  • 9. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R, Kawaoi A, Miyagi E, Li X, Suzuki K, Nakamura Y, Kakudo K.
    Mod Pathol; 2000 May 01; 13(5):570-6. PubMed ID: 10824930
    [Abstract] [Full Text] [Related]

  • 10. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M, Moon WS.
    Int J Oncol; 2009 Jul 01; 35(1):49-55. PubMed ID: 19513551
    [Abstract] [Full Text] [Related]

  • 11. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
    Yang Y.
    Zhonghua Yi Xue Za Zhi; 1991 Jun 01; 71(6):304-6, 22. PubMed ID: 1667490
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
    Baek SK, Woo JS, Kwon SY, Lee SH, Chae YS, Jung KY.
    Laryngoscope; 2007 May 01; 117(5):911-6. PubMed ID: 17473695
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
    Papadimitriou K, Yiagnisis M, Tolis G, Spandidos DA.
    Anticancer Res; 1988 May 01; 8(6):1223-7. PubMed ID: 3064713
    [Abstract] [Full Text] [Related]

  • 14. Distribution of Bcl-2 gene expression and its prognostic value in non-small cell lung cancer.
    Yilmaz A, Savaş I, Dizbay Sak S, Güngör A, Kaya A, Serinsöz E, Savaş B.
    Tuberk Toraks; 2005 May 01; 53(4):323-9. PubMed ID: 16456730
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical study of glypican 3 in thyroid cancer.
    Yamanaka K, Ito Y, Okuyama N, Noda K, Matsumoto H, Yoshida H, Miyauchi A, Capurro M, Filmus J, Miyoshi E.
    Oncology; 2007 May 01; 73(5-6):389-94. PubMed ID: 18511877
    [Abstract] [Full Text] [Related]

  • 16. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H, Zhang J, Lu J, He X, Chen C, Li X, Gong L, Bao G, Fu Q, Chen S, Lin W, Shi H, Ma J, Liu X, Ma Q, Yao L.
    BMC Cancer; 2008 Oct 22; 8():303. PubMed ID: 18940011
    [Abstract] [Full Text] [Related]

  • 17. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C, Martín-Campos JM, Lerma E, Gimenez G, Martínez-Guitarte JL, Combalía N, Montaner D, Matías-Guiu X, Dopazo J, de Leiva A, Robledo M, Mauricio D.
    Oncogene; 2008 Mar 06; 27(11):1554-61. PubMed ID: 17873908
    [Abstract] [Full Text] [Related]

  • 18. Bag-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation.
    Ito Y, Yoshida H, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kakudo K, Kuma K, Miyauchi A.
    Anticancer Res; 2003 Mar 06; 23(1B):569-76. PubMed ID: 12680148
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM, Adabi Kh, Lashkari A, Heshmat R, Haghpanah V, Larijani B, Tavangar SM.
    Pathol Res Pract; 2009 Mar 06; 205(2):83-7. PubMed ID: 18996649
    [Abstract] [Full Text] [Related]

  • 20. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
    Poincloux L, Durando X, Seitz JF, Thivat E, Bardou VJ, Giovannini MH, Parriaux D, Barriere N, Giovannini M, Delpero JR, Monges G.
    Surg Oncol; 2009 Dec 06; 18(4):357-65. PubMed ID: 19027288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.